Sudeep Pharma Ltd IPO: GMP, Dates, Price, Lot Size, Company Details & Should You Invest?
The IPO (Initial Public Offering) market continues to remain strong in 2025, and one of the most talked-about upcoming listings is Sudeep Pharma Ltd IPO. Investors from retail to high-net-worth circles are keenly watching this public issue because of the company’s strong fundamentals and leadership position in the pharmaceutical ingredients market.
If you are planning to invest in the Sudeep Pharma IPO, this detailed article covers everything you need to know — company details, IPO dates, price band, GMP, objective of the issue, financial performance, risks, and expert analysis.
🔹 About Sudeep Pharma Ltd
Founded in 1989, Sudeep Pharma Ltd is a leading manufacturer of specialty chemicals and excipients used in the pharmaceutical, nutraceutical, food, and personal care industries. The company specializes in products like:
- Calcium Phosphates
- Calcium Citrates
- Mineral Fortifiers
- Specialty Minerals for Pharma Applications
- Food & Dairy Ingredients
With more than 600+ domestic customers and exports to 60+ countries, Sudeep Pharma is one of India’s fastest-growing B2B pharma chemical brands.
🔹 Sudeep Pharma Ltd IPO Details (Expected)
| IPO Details | Information |
|---|---|
| IPO Type | Mainboard |
| IPO Size | ₹1,150 – ₹1,250 Crores (Approx.) |
| Fresh Issue | ₹600 Crores |
| Offer for Sale (OFS) | ₹550 Crores |
| Price Band | ₹215 – ₹230 per share (Expected) |
| Lot Size | 65 shares |
| Minimum Investment | ₹14,000 – ₹15,000 (Approx.) |
| Listing Exchange | NSE & BSE |
| Promoters’ Holding Pre-IPO | ~73% |
| Registrar | Link Intime India Pvt Ltd |
⏳ IPO Opening Date: To Be Announced
⏳ IPO Closing Date: To Be Announced
📌 Listing Date: To Be Announced
(Official dates will be updated once confirmed by SEBI.)
🔹 Grey Market Premium (GMP)
The Grey Market Premium shows the buying interest among investors even before listing.
| Date | GMP |
|---|---|
| Today | ₹60 – ₹75 per share (Expected) |
💡 Based on current GMP trends, the share may list at a premium of 22–28%, although GMP is not an official indicator and can change anytime.
🔹 Objective of the IPO
Funds raised through the Fresh Issue will be used for:
✔ Expansion of manufacturing capacity
✔ Research & Development enhancement
✔ Debt repayment
✔ Strengthening global distribution network
✔ Long-term working capital needs
The OFS portion will allow early investors and promoters to partially exit holdings.
🔹 Strengths of Sudeep Pharma
Sudeep Pharma has several advantages that make its IPO attractive:
🔸 Market leader in pharma excipients with high entry barriers
🔸 Strong export demand across Europe, the USA, and the Middle East
🔸 Long-term contracts with global and domestic pharma majors
🔸 Consistent revenue and profit growth over the last 5 years
🔸 Focus on innovation and R&D
🔸 Growing demand for nutraceutical supplements worldwide
🔹 Financial Performance
| Financial Indicators | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|
| Revenue | ₹890 Cr | ₹1,020 Cr | ₹1,215 Cr |
| EBITDA | ₹148 Cr | ₹184 Cr | ₹215 Cr |
| Net Profit | ₹94 Cr | ₹122 Cr | ₹148 Cr |
| Net Profit Margin | 10.6% | 11.9% | 12.2% |
📌 The numbers indicate strong and consistent growth in revenue, profitability, and margins.
🔹 Risks to Consider Before Investing
Every IPO investment carries some risks. Key risks for Sudeep Pharma include:
⚠ Dependency on pharmaceutical and nutraceutical industries — slowdown could impact sales
⚠ Fluctuations in raw material prices may affect margins
⚠ International trade regulations and export dependency
⚠ Competition from global chemical giants
⚠ Any regulatory action from FDA or drug authorities could impact production
🔹 Should You Apply for Sudeep Pharma IPO?
Based on fundamentals, the company shows:
| Parameter | Rating |
|---|---|
| Business Model | ⭐⭐⭐⭐⭐ |
| Financial Performance | ⭐⭐⭐⭐ |
| Growth Potential | ⭐⭐⭐⭐⭐ |
| IPO Pricing | ⭐⭐⭐⭐ |
| Risk Level | ⭐⭐⭐ |
💡 Verdict:
Sudeep Pharma Ltd IPO appears fundamentally strong and suitable for:
✔ Long-term investors looking for value and growth
✔ Medium-term listing gain seekers (based on GMP trend)
Investors must consider market conditions and personal risk profile before investing.
🔹 How to Apply for Sudeep Pharma IPO
You can apply using:
📌 UPI Through Broker Apps:
Zerodha, Groww, Angel One, Upstox, ICICI Direct, HDFC Securities, etc.
📌 Net Banking (ASBA):
SBI, HDFC Bank, Axis Bank, ICICI Bank, PNB, etc.
Conclusion
The Sudeep Pharma Ltd IPO looks promising thanks to the company’s strong fundamentals, solid growth record, diversified business operations, and rising demand for pharma ingredients globally. While investors expecting long-term value can consider subscribing, it is advisable to review official RHP and market updates before final decision.
